Clinical Trial Update: Biomarker Analysis in Metastatic Colorectal Cancer Treated With Cetuximab

View source ↗

Summary

Clinical trial update describing biomarker analyses in patients with colorectal cancer treated with cetuximab. The study is sponsored by Samsung Medical Center …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Samsung Medical Center | Conditions: Colorectal Cancer | Status: COMPLETED